MedPath

Reduction of Sweetened Beverages and Intrahepatic Fat

Not Applicable
Completed
Conditions
Obesity
Metabolic Syndrome
Dyslipidemia
Interventions
Other: artificially sweetened sodas
Registration Number
NCT01394380
Lead Sponsor
University of Lausanne
Brief Summary

The study will enroll 68 overweight male and female subjects with a high (\> 2 3dl-can soda/day) consumption of sweetened beverage per day. After a run-in period of 4 weeks, subjects will be randomized to either a 12-week intervention arm in which sweetened beverages will be replaced by artificially sweetened, calorie-free beverages, or to a control arm. The following measurements will be performed at the end of the run-in period and at the end of the intervention period

* intrahepatic fat concentration

* visceral fat volume

* changes in day-long metabolic profile from baseline(plasma glucose, insulin, and triglyceride concentrations)

* changes in food intake and daily energy, carbohydrate and sugars intake from baseline

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
29
Inclusion Criteria
  • gender male or female
  • body mass index (BMI) > 27 kg/m2 consumption of > 2 3dl-can regular soda/day
  • low to moderate physical activity (< 60 min walking/day; < 3 exercise session/week
Exclusion Criteria
  • diabetes mellitus
  • liver, kidney or heart disease
  • any current drug treatment
  • contra-indications to MR examination (pacemaker, foreign bodies,etc)
  • pregnancy or planned pregnancy
  • active weight gain or weight loss (weight change > 4 kg in the past 12 months)
  • consumption of drugs or illicit substances
  • consumption of more than 10g alcohol/day
  • vegetarians or subjects on special diets

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
artificially sweetened beveragesartificially sweetened sodassubjects will be required to consume only artificially-sweetened sodas, water, tea or coffee
Primary Outcome Measures
NameTimeMethod
changes in intrahepatic fat concentrationat the end of run-in and after 12 weeks intervention/control

intrahepatic fat content measured by 1H-MRS

Secondary Outcome Measures
NameTimeMethod
changes in food intake from baselineat the end of the run-in period and after 6, and 12 weeks of intervention/control

Total energy intake, total carbohydrate intake, and total sugars intake will be evaluated by 3-day food record

changes in visceral fat volumeat the end of run-in and after 12 weeks of intervention/control

Visceral fat volume measured by MRI

changes in day-long metabolic profileat the end of run-in and after 12 weeks of intervention/control

Plasma glucose, insulin, non-esterified fatty acids, and triglycerides will be measured at 2-hourly intervals between 7:00 am and 5:00 pm. Participants will be fed standardized meals and either sweetened or artificially-sweetened beverages according to randomization

Trial Locations

Locations (1)

Clinical Research Center, CHUV

🇨🇭

Lausanne, VD, Switzerland

© Copyright 2025. All Rights Reserved by MedPath